MedTrace Logo

Effects of Transcranial Magnetic Stimulation After Endovascular Treatment for Acute Ischemic Stroke

NCT06639360 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2025-12-04

No results posted yet for this study

Summary

This is a multicenter, randomized, double-blind, sham-controlled trial, to determine the efficacy and safety of cTBS in treating patients with acute ischemic stroke after endovascular treatment.

Conditions

  • Ischemic Stroke, Acute
  • Endovascular Thrombectomy

Interventions

DEVICE

Transcranial Magnetic Stimulation Active

The patients will be treated with cTBS and usual medical treatment after endovascular treatment

DEVICE

Transcranial Magnetic Stimulation Sham

The patients will be treated with sham-cTBS and usual medical treatment after endovascular treatment

Sponsors & Collaborators

  • Xijing Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-08-02
Primary Completion
2026-09-30
Completion
2026-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06639360 on ClinicalTrials.gov